| Financial Year |
March 31 2022 |
| Monetary Funds |
137,099,866.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
72,608,203.59 |
| Accounts Receivable |
751,691,713.20 |
| Advances to Suppliers |
58,199,551.38 |
| Other Receivables |
12,026,311.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
612,324,234.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,291,994.15 |
| Total Current Assets |
1,771,623,837.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
986,411,887.78 |
| Under-construction Projects |
103,801,435.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,588,236.10 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,156,088.33 |
| Deferred Income Tax Assets |
34,920,640.35 |
| Other Non-Current Assets |
41,582,321.61 |
| Sub-Total of Non-Current Assets |
1,236,904,872.17 |
| Total Assets |
3,008,528,709.87 |
| Short-Term Loans |
463,957,491.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
409,790,023.91 |
| Accounts Payable |
193,369,347.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,418,478.52 |
| Taxes Payable |
7,540,911.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,796,273.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
59,962,749.32 |
| Other Current Liabilities |
95,643,827.28 |
| Sub-Total of Current Liabilities |
1,316,710,713.58 |
| Long-term Loans |
7,760,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
23,416,283.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
68,756,130.40 |
| Total Liabilities |
1,385,466,843.98 |
| Paid-In Capital(Or Share Stock) |
393,360,743.00 |
| Capital Surplus |
591,806,895.33 |
| Surplus Reserve |
69,889,114.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
564,096,834.94 |
| Minority Stockholder's Interest |
3,365,994.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,619,695,871.44 |
| Owner's Equity（Stockholder's Equity） |
1,623,061,865.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,008,528,709.87 |
